New Frontiers for Early-life Nutrition: All G and Armor Protéines Announce Joint Venture to Scale Human and Bovine Lactoferrin as All G Closes A$10 Million Round
SYDNEY–(BUSINESS WIRE)–Australian biotech All G has raised over A$10 million in a convertible note round ahead of its Series B raise, injecting additional capital for commercial-scale production of its first bovine lactoferrin product due to launch in Q1 2026. In parallel, All G and French global bioactives leader Armor Protéines have established a joint venture … [Read more…]
